Literature DB >> 93987

Pharmacokinetics of bleomycin in man. III. Bleomycin 57Co Vs bleomycin.

D S Alberts, H S Chen, J M Woolfenden, T E Moon, S Y Chang, J N Hall, K J Himmelstein, J Gross, S E Salmon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93987     DOI: 10.1007/bf00254417

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  15 in total

1.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

2.  [Cobalt-57 labeled bleomycin metabolism in the mouse. 1. Distribution and Kinetics].

Authors:  J Robert; H Renault; J Rapin; M Rudler; J P Nouel
Journal:  Therapie       Date:  1973 Sep-Oct       Impact factor: 2.070

3.  Distribution of labeled bleomycin in normal and tumor-bearing mice.

Authors:  R B Grove; W C Eckelman; R C Reba
Journal:  J Nucl Med       Date:  1973-12       Impact factor: 10.057

4.  Bleomycin pharmacokinetics in man. I. Intravenous administration.

Authors:  D S Alberts; H S Chen; R Liu; K J Himmelstein; M Mayersohn; D Perrier; J Gross; T Moon; A Broughton; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

5.  Specificity of antisera produced against bleomycin.

Authors:  J E Strong; A Broughton; S T Crooke
Journal:  Cancer Treat Rep       Date:  1977-11

6.  Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67.

Authors:  M A van de Poll; A Versluis; J J Rasker; H Jurjens; M G Woldring
Journal:  Nuklearmedizin       Date:  1976-04       Impact factor: 1.379

7.  Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate.

Authors:  K P Poulose; A E Watkins; R C Reba; W C Eckelman; M Goodyear
Journal:  J Nucl Med       Date:  1975-09       Impact factor: 10.057

8.  Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.

Authors:  J J Rasker; A M Poll; H Beekhuis; M G Woldring; H O Nieweg
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

Review 9.  Cobalt-57 bleomycin for imaging head and neck tumors.

Authors:  J M Woolfenden; D S Alberts; J N Hall; D D Patton
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

10.  The place of 57Co-bleomycin scanning in the evaluation of tumors.

Authors:  P C Kahn; C Milunsky; M K Dewanjee; R A Rudders
Journal:  AJR Am J Roentgenol       Date:  1977-08       Impact factor: 3.959

View more
  3 in total

1.  Therapy operating characteristic curves: tools for precision chemotherapy.

Authors:  Harrison H Barrett; David S Alberts; James M Woolfenden; Luca Caucci; John W Hoppin
Journal:  J Med Imaging (Bellingham)       Date:  2016-05-02

2.  Quantifying and Reducing Uncertainties in Cancer Therapy.

Authors:  Harrison H Barrett; David S Alberts; James M Woolfenden; Zhonglin Liu; Luca Caucci; John W Hoppin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-02-21

3.  [Animal experiments for intratumoral chemotherapy with bleomycin (author's transl)].

Authors:  J Bier; H Bier; B Lathan; T Siegel; S Ohanian
Journal:  Arch Otorhinolaryngol       Date:  1980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.